SPL 0.00% 8.9¢ starpharma holdings limited

I believe the CEO is pursuing sale of the DEP cancer drug...

  1. 4,827 Posts.
    lightbulb Created with Sketch. 249
    I believe the CEO is pursuing sale of the DEP cancer drug platform the sale will include all current in house drugs along with a large patent portfolio and listed applications. The sale will create a large cash chest for Starpharma to pursue their existing products and applications, the CEO hinted at this possibility in a recent interview. As far as potential value of moneyterizing the platform I am not sure something approaching $400m I would guess. This is just my opinion and not financial advice.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
0.000(0.00%)
Mkt cap ! $36.67M
Open High Low Value Volume
9.0¢ 9.1¢ 8.7¢ $257.5K 2.884M

Buyers (Bids)

No. Vol. Price($)
3 119243 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 60378 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.